Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxygen Radical Formation Antagonist
- Molecular classification
- Enzyme, Small Molecule, Protein
01
Overview
An oxygen radical formation antagonist is any molecule, compound, or biological agent that inhibits the generation or activity of reactive oxygen species (ROS). These antagonists are crucial in protecting cells and tissues from oxidative stress and damage. They encompass a broad range of substances, including antioxidant enzymes (e.g., superoxide dismutase, catalase, glutathione peroxidase) and non-enzymatic antioxidants (e.g., vitamins C and E, polyphenols). The balance between ROS production and removal by these antagonists is critical for cellular health and the prevention of various diseases.
- Other names
- Reactive Oxygen Species (ROS) InhibitorAntioxidantFree Radical ScavengerOxidative Stress Reducer
02
Mechanism of action
Scavenges free radicals; inhibits prooxidant enzymes (e.g., NADPH oxidase, xanthine oxidase); chelates metal ions that catalyze free radical formation; reduces levels of ROS
03
Biological functions
Antioxidant defenseRedox homeostasisCell signaling regulation (indirectly)Protection against oxidative damage
04
Disease associations
Cardiovascular diseaseCancerNeurodegenerative diseaseInflammationAging-related disordersIschemia-reperfusion injuryDiabetes
05
Safety considerations
Potential for antioxidant paradox (high doses may have pro-oxidant effects)Drug interactions (e.g., with chemotherapy)Variability in efficacy based on individual factors (genetics, diet, lifestyle)Dosage-dependent toxicity
06
Interacting drugs
N-Acetylcysteine (NAC)
5 more in the full profile.
07
Biomarkers
Levels of ROS (e.g., superoxide, hydrogen peroxide)Markers of oxidative damage (e.g., malondialdehyde, 8-OHdG)Levels of antioxidant enzymes (e.g., SOD, catalase, glutathione peroxidase)Glutathione levelsInflammatory markers (e.g. CRP, IL-6, TNF-alpha) as indirect biomarkers of oxidative stress
Beyond the preview
Go deeper on Oxygen Radical Formation Antagonist.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oxygen Radical Formation Antagonist.